Medical Hypotheses
Volume 57, Issue 2 , Pages 139-145 , August 2001

Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite

Received 19 October 2000 ,Accepted 19 October 2000.

References 

    REFERENCES
  1. Donnay A, Ziem G. Prevalence and overlap of chronic fatigue syndrome and fibromylagia syndrome among 100 new patients with multiple chemical sensitivity. J Chronic Fatigue Syndr. 1999;5:71–80
  2. Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, amd multiple chemical sensitivities. Arch Int Med. 1994;154:2049–2053
  3. Bell IR, Baldwin CM, Schwartz GE. Illness from low levels of environmental chemicals: relevance to chronic fatigue syndrome and fibromyalgia. Am J Med. 1998;105:74S–82S
  4. Clauw DJ, Crousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroemmunomodulation. 1997;4:134–153
  5. White KP, Speechley M, Harth M, Ostbye T. Co-existence of chronic fatigue syndrome with fibromyalgia in the general population – A controlled study. Scand J Rheum. 2000;29:44–51
  6. Ziem G, Donnay A. Chronic fatigue, fibromyalgia, and chemical sensitivity: overlapping disorders. Arch Intern Med. 1995;155:1913
  7. Arnetz BB. Model development and research vision for the future of multiple chemical sensitivity. Scand J Work Environ Health. 1999;25:569–573
  8. Bell IR, Baldwin CM, Russek LG, Schwartz GE, Hardin EE. Early life stress, negative paternal relationships, and chemical intolerance in middle-aged women: support for a neural sensitization model. J Womens Health. 1998;7:1135–1147
  9. Sherman JJ, Turk DC, Okifuji A. Prevalence and impact of posttraumatic stress disorder-like symptoms on patients with fibromyalgia syndrome. Clin J Pain. 2000;16:127–134
  10. Pall ML. Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. Med Hypoth. 2000;54:115–125
  11. Pall ML. Elevated peroxynitrite as the cause of chronic fatigue syndrome: Other inducers and mechanisms of symptom generation. J Chronic Fatigue Syndr. 2000;7:45–58
  12. Pall ML. Cobalamin used in chronic fatigue syndrome therapy is a nitric oxide scavenger. J Chronic Fatigue Syndr. 2001;8:39–44
  13. Pall ML, Satterlee JD. Elevated nitric oxide/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome and posttraumatic stress disorder. Ann N Y Acad Sci. 2001;933:323–329
  14. Miller CS. Are we on the threshold of a new theory of disease? Toxicant-induced loss of tolerance and its relationship to addiction and abdiction. Toxicol Ind Health. 1999;15:284–294
  15. Heresco Levy U, Javitt DC. The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotranmission in the pathophysiology and therapeutics of psychiatric syndromes. Eur Neuropharmacol. 1998;8:141–152
  16. McEwen BS. Possible mechanisms for atrophy of the human hippocampus. Mol Psychiatry. 1997;2:255–262
  17. Chambers RA, Bremner JD, Moghaddam B, Southwick SM, Charney DS, Krystal JH. Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation. Semin Clin Neuropsychiatry. 1999;4:274–281
  18. Goldstein LE, Rasmussen AM, Bunney BS, Roth RH. Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefontal cortical monoamine responses to psychological stress in the rat. J Neurosci. 1996;16:4787–4798
  19. Lafon Cazal M, Culcasi M, Gaven F, Pietri S, Bockaert J. Nitric oxide, superoxide and peroxynitrite: putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharmacology. 1993;32:1259–1266
  20. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegerative disorders. Science. 1993;262:689–695
  21. Culcasi M, Lafon Cazal M, Pietri S, Bockaert J. Glutamate receptors induce a burst of superoxide via activation of superoxide synthase in arginine-depleted neurons. J Biol Chem. 1994;269:12589–12593
  22. Lafon Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 1993;364:535–537
  23. Bindokas VP, Jordan J, Lee CC, Miller RJ. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J Neurosci. 1996;16:1324–1336
  24. Reynolds IJ, Hastings TG. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci. 1995;15:3318–3327
  25. Beckman JS. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol. 1991;15:53–59
  26. Alptekin N, Seçkin S, Dogru Abbasoglu S, Yelkenci F, Koçak Toker N, Toker G, et al. Lipid peroxides, glutathione, gamma-glutamylcysteine synthetase and gamma-glutamyltranspeptidase activities in several tissues of rats following water-immersion stress. Phamacol Res. 1996;34:167–169
  27. Seçkin S, Alptekin N, Dogru Abbasoglu S, Koçak Toker N, Toker G, Uysal M. The effect of chronic stress on hepatic and gastric lipid peroxidation in long-term depletion of glutathione in rats. Pharmacol Res. 1997;36:55–57
  28. Konstandi M, Marselos M, Radon Camus AM, Johnson E, Lang MA. The role of stress in regulation of drug metabolizing enzymes in mice. Eur J Drug Metab Phamacokinet. 1998;23:483–490
  29. Adamec RE, Burton P, Shallow T, Budgell J. NMDA receptors mediate lasting increases in anxiety-like behavior produced by the stress of predator exposure-implications for anxiety associated with posttraumatic stress disorder. Physiol Behav. 1999;65:723–737
  30. Goldstein LE, Rasmussen AM, Bunney BS, Roth RH. The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesofrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study. J Neurosci. 1994;14:4937–4950
  31. Laudanno OM, Cesolari JA, San Miguel P, Bedini OA. Role of inducible nitric oxide synthase in acute gastric mucosal damage in stress, in rats. Acta Gastroenterol Latinoam. 1996;26:221–224
  32. Spivak B, Shohat B, Mester R, Avraham S. Elevated levels of serum interleukin-1b in combat-related posttraumatic stress disorder. Biol Psychiatry. 1997;42:345–348
  33. Maes M, Lin AH, Delmeire L. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry. 1999;45:833–839
  34. Hanin, I. 1996, The Gulf War, stress and a leaky blood-brain barrier. Nature Med, 1996, 2, 1307, 1308
  35. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I. Pyridostigmine brain penetration under stress inhances neuronal excitability and induces early immediate transcriptional response. Nature Med. 1996;2:1382–1385
  36. Sharma HS, Cervos-Navarro J, Dey PK. Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive rats. Neurosci Res. 1991;10:211–221
  37. Imaizumi S, Kondo T, Deli MA. The influence of oxygen free radicals on the permeability of the monolayer of cultured brain endothelial cells. Neurochem Int. 1996;;
  38. Kastenbauer S, Koedel U, Pfister HW. Role of peroxynitrite as a mediator of pathophysiological alterations in experimental meningitis. J Infect Dis. 1999;180:1164–1170
  39. Calingasan NY, Park LC, Calo LL, Trifiletti RR, Gandy SE, Gibson GE. Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism. Am J Pathol. 1998;153:599–610
  40. Ikeda K, Nagashima T, Wu S, Yamaguchi M, Tamaki N. The role of calcium ion in anoxia/reoxygenation damage of cultured brain capillary endothelial cells. Acta Neurochir Suppl. 1997;70:4–7
  41. Waylonis GW, Perkins RH. Post-traumatic fibromyalgia. A long-term follow-up. Am J Phys Med Rehabil. 1994;73:403–412
  42. Buskila D, Neumann L, Vaisberg G, Alakalay D, Wolfe F. Increased rates of fibromylagia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis Rheum. 1997;40:446–452
  43. Greenfield S, Fitzcharled MA, Esdaile JM. Reactive fibromylagia syndrome. Arthritis Rheum. 1992;35:678–681
  44. Aaron LA, Bradley LA, Alacon GS. Perceived physical and emotional trauma as precipitating events in fibromyalgia. Associations with health care seeking and disability status but not pain severity. Arthritis Rheum. 1997;40:453–460
  45. Gebhard F, Nüssler AK, Rösch M, Pfetsch H, Kinzl L, Brückner UB. Early posttraumatic increase in production of nitric oxide in humans. Shock. 1998;10:237–242
  46. Larson AA, Glovengo SL, Russel IJ, Michalek JE. Changes in the concentration of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain. 2000;87:201–211
  47. Sörensen J, Bengtsson A, Bäckman E, Henriksson KG, Bengtsson M. Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol. 1995;24:360–365
  48. Nicolodi M, Volpe AR, Sicuteri F. Fibromyalgia and headache. Failure of serotonergic analgesia and N-methyl- D-aspartate-mediated neuronal plasticity: their common clues. Cephalalgia. 1998;18:41–44
  49. Graven Nielsen T, Aspegren Kendall S, Henriksson KG. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain. 2000;85:483–491
  50. Yunus MB, Kalyan Raman UP, Kalyan Raman K. Primary fibromyalgia syndrome and myofascial pain syndrome: clinical features and muscle pathology. Arch Phys Med Rehabil. 1988;69:451–454
  51. Pongratz DE, Späth M. Morphologic aspects of fibromyalgia. Z Rheumatol. 1998;57:47–51
  52. Kalyan Raman UP, Kalyan Raman K, Yunus MB, Masi AT. Muscle pathology in primary fibromyalgia syndrome: a light microscopic, histochemical and ultrastructural study. J Rheumatol. 1984;11:808–813
  53. Park JH, Phothimat P, Oates CT, Hernanz Schulman M, Olsen NJ. Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles in patients with fibromylagia. Arthritis Rheum. 1998;41:406–413
  54. Radhakrishnan V, Hui Chan CW, Henry JL. Implication of a nitric oxide synthase mechanism in the action of substance P: L-NAME blocks thermal hyperalgesia induced by endogenous and exogenous substance P in the rat. Eur J Neurosci. 1995;7:1920–1925
  55. Lewin MR, Walters ET. Cyclic GMP pathway is critical for inducing long-term sensitization of nociceptor sensory neurons. Nat Neurosci. 1999;2:18–23
  56. Aley KO, McCarter G, Levine JD. Nitric oxide signalling in pain and nociceptor sensitization in the rat. J Neurosci. 1998;18:1014–7008
  57. Thomsen LL, Olesen J. Nitric oxide theory of migraine. Clin Neurosci. 1998;5:28–33
  58. Thomsen LL. Investigations into the role of nitric oxide and the large intracranial arteries in migraine headache. Cephalalgia. 1997;17:873–895
  59. The lowa Persian Gulf Study Group. Self-reported illness and health status among Gulf War veterans – a population-based study. JAMA. 1997;227:238–245
  60. Kipen HM, Hallman W, Kang H, Fiedler N, Natelson BH. Prevalence of chronic fatigue and chemical sensitivities in Gulf Registry Veterans. Arch Environm Health. 1999;54:313–318
  61. Pollet C, Natelson BH, Lange G. Medical evaluation of Persian Gulf veterans with fatigue and/or chemical sensitivity. J Med. 1998;29:101–113
  62. Nicolson GL, Nicolson NL. Gulf War illnesses: complex medical, scientific paradox. Med Confl Surviv. 1998;14:156–165
  63. Hodgson MJ, Kipen HM. Gulf War illnesses: causation and treatment. J Occup Environ Med. 1999;41:443–452
  64. Baker DG, Mendenhall CL, Simbartl LA, Magan LK, Steinberg JL. Relationship between posttraumatic stress disorder and self-reported physical symptoms in Persian Gulf War veterans. Arch Intern Med. 1997;;
  65. Weaver LK. Carbon monoxide posioning. Crit Care Clin. 1999;15:297–317
  66. Kelefant GA. Encephalopathy and peripheral neuropathy following carbon monoxide poisoning from a propane-fueled vehicle. Am J Ind Med. 1996;30:765–768
  67. Gabrielli A, Layon AJ. Carbon monoxide intoxication during pregnancy: a case presentation and pathophysiologic discussion, with emphasis on molecular mechanisms. J Clin Anesth. 1995;7:82–87
  68. Adir Y, Bentur Y, Melamed Y. Hyperbaric oxygen and neuropschiatric sequelae of carbon monoxide poisoning. Harefuah. 1992;122:562–563
  69. Yoshii F, Kozuma R, Takahashi W, Haida M, Takagi S, Shinohara Y. Magnetic resonance imaging and 11C- N-methylspiperone/positron emission tomography studies in a patient with the interval form of carbon monoxide poisoning. J Neurol Sci. 1998;160:87–91
  70. Gibson AJ, Davis FM, Ewer T, McGeoch G. Delayed hyperbaric oxygen therapy for carbon monoxide intoxication–two case reports. N Z Med J. 1991;104:64–65
  71. Sakamoto K, Murata T, Omori M. Clinical studies on three cases of the interval form of carbon monoxide poisoning: serial proton magnetic resonance spectroscopy. Psychiatry Res. 1998;83:179–192
  72. Thomson LF, Mardel SN, Jack A, Shields TG. Management of the moribund carbon monoxide victim. Arch Emerg Med. 1992;;
  73. Kales SN. Carbon monoxide intoxication. Am Fam Physician. 1993;48:1100–1104
  74. Dolan MC, Haltom TL, Barrows GH, Short CS, Ferriell KM. Carboxyhemoglobin levels in patients with flu-like symptoms. Ann Emerg Med. 1987;16:782–786
  75. Ely EW, Moorehead B, Haponik EF. Warehouse worker’s headache: emergency evaluation and management of 30 patients with carbon monoxide poisoning. Am J Med. 1995;98:145–155
  76. Greenwood C, Wilson MT, Brunori M. Studies on partially reduced cytochrome oxidase. Reactions with carbon monoxide and oxygen. Biochem J. 1974;;
  77. Miró O, Casademont J, Barrientos A, Urbano Márquez A, Cardellach F. Mitochondial cytochrome C oxidase inhibition during acute carbon monoxide poisoning. Pharmacol Toxicol. 1998;82:199–202
  78. Vanden Hoek TL, Becker LB, Shao Z, Li C, Schumacker PT. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem. 1998;273:18092–18098
  79. Russell WJ, Jackson RM. Hydrogen peroxide release by mitochondria from normal and hypoxic lungs. Am J Med Sci. 1994;308:239–243
  80. Smith DR, Stone D, Darley Usmar VM. Stimulation of mitochondrial oxygen consumption in isolated cardiomyocytes after hypoxia-reoxygenation. Free Radic Res. 1996;24:159–166
  81. Jaeshcke H, Mitchell JR. Mitochondria and xanthine oxidase both generate reactive oxygen species in isolated perfused rate liven after hypoxic injury. Biochem Biophys Res Commun. 1989;160:140–147
  82. McCord JM, Roy RS. The pathophysiology of superoxide: roles in inflammation and ischemia. Can J Physiol Pharmacol. 1982;60:1346–1352
  83. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:150–163
  84. Thom SR. Dehydrogenase conversion to oxidase and lipid peroxidation in brain after carbon monoxide poisoning. J Appl Physiol. 1992;73:1584–1589
  85. Zhang J, Piantodosi CA. Mitochondrial oxidative stress after carbon monoxide hypoxia in rat brain. J Clin Invest. 1992;90:1193–1199
  86. Thom SR, Ohnishi ST, Ischiropoulos H. Nitric oxide released by platelets inhibits neutrophil B2 integrin function following acute carbon monoxide poisoning. Toxicol Appl Pharmacol. 1994;128:105–110
  87. Thom SR, Xu YA, Ischiropoulos H. Vascular endothelial cells generate peroxynitrite in response to carbon monoxide exposure. Chem Res Toxicol. 1997;10:1023–1031
  88. Thom SR, Kang M, Fisher D, Ishiropoulos H. Release of glutathione from erythrocytes and other markers of oxidative stress in carbon monoxide poisoning. J Appl Physiol. 1997;82:1424–1432
  89. Thom SR, Ischiropoulos H. Mechanism of oxidative stress from low levels of carbon monoxide. Res Rep Health Eff Inst. 1997;80:1–19
  90. Miró O, Alonso JR, Casademont J, Jarreta D, Urbano Márquez A, Cardellach F. Oxidative damage on lymphocyte membranes is increased in patients suffering from acute carbon monoxide poisoning. Toxicol Lett. 1999;110:219–223
  91. Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J. 1998;12:929–937
  92. Van de Kerkhof. Textbook of Psoriasis. Oxford: Blackwell Science Ltd.,. 1999;

PII: S0306-9877(01)91325-8

doi: 10.1054/mehy.2001.1325

Medical Hypotheses
Volume 57, Issue 2 , Pages 139-145 , August 2001

Article Tools